Low protein diet protects the liver from Salmonella Typhimurium-mediated injury by modulating the mTOR/autophagy axis in macrophages.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 12 03 2024
accepted: 20 09 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: epublish

Résumé

Western diets are the underlying cause of metabolic and liver diseases. Recent trend to limit the consumption of protein-rich animal products has become more prominent. This dietary change entails decreased protein consumption; however, it is still unknown how this affects innate immunity. Here, we studied the influence of a low protein diet (LPD) on the liver response to bacterial infection in mice. We found that LPD protects from Salmonella enterica serovar Typhimurium (S. Typhimurium)-induced liver damage. Bulk and single-cell RNA sequencing of murine liver cells showed reduced inflammation and upregulation of autophagy-related genes in myeloid cells in mice fed with LPD after S. Typhimurium infection. Mechanistically, we found reduced activation of the mammalian target of rapamycin (mTOR) pathway, whilst increased phagocytosis and activation of autophagy in LPD-programmed macrophages. We confirmed these observations in phagocytosis and mTOR activation in metabolically programmed human peripheral blood monocyte-derived macrophages. Together, our results support the causal role of dietary components on the fitness of the immune system.

Identifiants

pubmed: 39349819
doi: 10.1038/s42003-024-06932-w
pii: 10.1038/s42003-024-06932-w
doi:

Substances chimiques

TOR Serine-Threonine Kinases EC 2.7.11.1
mTOR protein, mouse EC 2.7.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1219

Subventions

Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/R012490/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/F/000PR10355
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/CCG1860/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/X011054/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/F/000PR13632
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/X011011/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/F/000PR13634
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/W002450/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/CCG1720/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBX011070/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/T008717/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/P022073/1
Organisme : Wellcome Trust (Wellcome)
ID : 213731/Z/18/Z
Organisme : Wellcome Trust (Wellcome)
ID : 220534/Z/20/Z
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/T02934X/1

Informations de copyright

© 2024. The Author(s).

Références

Childs, C. E., Calder, P. C. & Miles, E. A. Diet and Immune Function. Nutrients 11, 1933 (2019).
Schulze, M. B., Martinez-Gonzalez, M. A., Fung, T. T., Lichtenstein, A. H. & Forouhi, N. G. Food based dietary patterns and chronic disease prevention. BMJ 361, k2396 (2018).
pubmed: 29898951 pmcid: 5996879 doi: 10.1136/bmj.k2396
Christ, A. et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172, 162–175.e114 (2018).
pubmed: 29328911 pmcid: 6324559 doi: 10.1016/j.cell.2017.12.013
Cildir, G., Akincilar, S. C. & Tergaonkar, V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol. Med. 19, 487–500 (2013).
pubmed: 23746697 doi: 10.1016/j.molmed.2013.05.001
Netea, M. G. et al. Trained immunity: A program of innate immune memory in health and disease. Science 352, aaf1098 (2016).
pubmed: 27102489 pmcid: 5087274 doi: 10.1126/science.aaf1098
Kaspersen, K. A. et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology 26, 580–589 (2015).
pubmed: 25978794 doi: 10.1097/EDE.0000000000000301
Maccioni, L. et al. Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health 18, 271 (2018).
pubmed: 29458350 pmcid: 5819164 doi: 10.1186/s12889-018-5172-8
Mariotti, F. & Gardner, C. D. Dietary protein and amino acids in vegetarian diets—a review. Nutrients 11, 2661 (2019).
Brown, E. M. et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat. Commun. 6, 7806 (2015).
pubmed: 26241678 doi: 10.1038/ncomms8806
Onyango, A. W., Jean-Baptiste, J., Samburu, B. & Mahlangu, T. L. M. Regional overview on the double burden of malnutrition and examples of program and policy responses: african region. Ann. Nutr. Metab. 75, 127–130 (2019).
pubmed: 31743899 doi: 10.1159/000503671
Rivadeneira, D. E. et al. Malnutrition-induced macrophage apoptosis. Surgery 129, 617–625 (2001).
pubmed: 11331454 doi: 10.1067/msy.2001.112963
Salameh, E., Morel, F. B., Zeilani, M., Dechelotte, P. & Marion-Letellier, R. Animal models of undernutrition and enteropathy as tools for assessment of nutritional intervention. Nutrients 11, 2233 (2019).
Fontana, L. et al. Dietary protein restriction inhibits tumor growth in human xenograft models. Oncotarget 4, 2451–2461 (2013).
pubmed: 24353195 pmcid: 3926840 doi: 10.18632/oncotarget.1586
Levine, M. E. et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 19, 407–417 (2014).
pubmed: 24606898 pmcid: 3988204 doi: 10.1016/j.cmet.2014.02.006
Solanki, S. et al. Dysregulated amino acid sensing drives colorectal cancer growth and metabolic reprogramming leading to chemoresistance. Gastroenterology 164, 376–391.e313 (2023).
pubmed: 36410445 doi: 10.1053/j.gastro.2022.11.014
Ginhoux, F. & Guilliams, M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439–449 (2016).
pubmed: 26982352 doi: 10.1016/j.immuni.2016.02.024
Arango Duque, G. & Descoteaux, A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5, 491 (2014).
pubmed: 25339958 pmcid: 4188125 doi: 10.3389/fimmu.2014.00491
Hirayama, D., Iida, T. & Nakase, H. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int. J. Mol. Sci. 19, 92 (2017).
Ilyas, B., Tsai, C. N. & Coombes, B. K. Evolution of Salmonella-host cell interactions through a dynamic bacterial genome. Front. Cell Infect. Microbiol. 7, 428 (2017).
pubmed: 29034217 pmcid: 5626846 doi: 10.3389/fcimb.2017.00428
Robinson, N. et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13, 954–962 (2012).
pubmed: 22922364 pmcid: 4005791 doi: 10.1038/ni.2397
Ganesan, R. et al. Salmonella Typhimurium disrupts Sirt1/AMPK checkpoint control of mTOR to impair autophagy. PLoS Pathog. 13, e1006227 (2017).
pubmed: 28192515 pmcid: 5325604 doi: 10.1371/journal.ppat.1006227
Giovannini, L. & Bianchi, S. Role of nutraceutical SIRT1 modulators in AMPK and mTOR pathway: Evidence of a synergistic effect. Nutrition 34, 82–96 (2017).
pubmed: 28063518 doi: 10.1016/j.nut.2016.09.008
Weichhart, T., Hengstschlager, M. & Linke, M. Regulation of innate immune cell function by mTOR. Nat. Rev. Immunol. 15, 599–614 (2015).
pubmed: 26403194 pmcid: 6095456 doi: 10.1038/nri3901
Orecchioni, M., Ghosheh, Y., Pramod, A. B. & Ley, K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 10, 1084 (2019).
pubmed: 31178859 pmcid: 6543837 doi: 10.3389/fimmu.2019.01084
Palmieri, E. M. et al. Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat. Commun. 11, 698 (2020).
pubmed: 32019928 pmcid: 7000728 doi: 10.1038/s41467-020-14433-7
Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 21, 347 (2015).
pubmed: 29510100 doi: 10.1016/j.cmet.2015.01.017
Wallace, C. & Keast, D. Glutamine and macrophage function. Metabolism 41, 1016–1020 (1992).
pubmed: 1381459 doi: 10.1016/0026-0495(92)90130-3
Rodriguez, A. E. et al. Serine metabolism supports macrophage IL-1beta production. Cell Metab. 29, 1003–1011.e1004 (2019).
pubmed: 30773464 pmcid: 6447453 doi: 10.1016/j.cmet.2019.01.014
Ellyard, J. I., Quah, B. J., Simson, L. & Parish, C. R. Alternatively activated macrophage possess antitumor cytotoxicity that is induced by IL-4 and mediated by arginase-1. J. Immunother. 33, 443–452 (2010).
pubmed: 20463604 doi: 10.1097/CJI.0b013e3181cd8746
Son, S. M. et al. Leucine signals to mTORC1 via its metabolite acetyl-coenzyme A. Cell Metab. 29, 192–201.e197 (2019).
pubmed: 30197302 pmcid: 6331339 doi: 10.1016/j.cmet.2018.08.013
Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M. & Ruggero, D. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell 157, 1088–1103 (2014).
pubmed: 24855946 pmcid: 4140650 doi: 10.1016/j.cell.2014.03.052
Huang, J. & Brumell, J. H. Bacteria-autophagy interplay: a battle for survival. Nat. Rev. Microbiol. 12, 101–114 (2014).
pubmed: 24384599 pmcid: 7097477 doi: 10.1038/nrmicro3160
Isaacs-Ten, A. et al. Metabolic regulation of macrophages by SIRT1 determines activation during cholestatic liver disease in mice. Cell Mol. Gastroenterol. Hepatol. 13, 1019–1039 (2022).
pubmed: 34952202 doi: 10.1016/j.jcmgh.2021.12.010
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Wood, G. et al. Salmonella impairs macrophage immunity through effector-independent rapid translational induction in response to membrane puncture by the SPI-1 injectisome. bioRxiv https://doi.org/10.1101/2023.07.21.550113 (2024).
Jia, L. et al. The roles of TNFAIP2 in cancers and infectious diseases. J. Cell Mol. Med. 22, 5188–5195 (2018).
pubmed: 30145807 pmcid: 6201362 doi: 10.1111/jcmm.13822
Schwanzer-Pfeiffer, D., Rossmanith, E., Schildberger, A. & Falkenhagen, D. Characterization of SVEP1, KIAA, and SRPX2 in an in vitro cell culture model of endotoxemia. Cell Immunol. 263, 65–70 (2010).
pubmed: 20236627 doi: 10.1016/j.cellimm.2010.02.017
Lee, W. B. et al. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages. BMB Rep. 52, 133–138 (2019).
pubmed: 30078389 pmcid: 6443328 doi: 10.5483/BMBRep.2019.52.2.129
Pruenster, M., Vogl, T., Roth, J. & Sperandio, M. S100A8/A9: from basic science to clinical application. Pharmacol. Ther. 167, 120–131 (2016).
pubmed: 27492899 doi: 10.1016/j.pharmthera.2016.07.015
Quintero, P. A., Knolle, M. D., Cala, L. F., Zhuang, Y. & Owen, C. A. Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J. Immunol. 184, 1575–1588 (2010).
pubmed: 20042585 doi: 10.4049/jimmunol.0900290
Maruyama, K., Sano, G., Ray, N., Takada, Y. & Matsuo, K. c-Fos-deficient mice are susceptible to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 75, 1520–1523 (2007).
pubmed: 17178788 doi: 10.1128/IAI.01316-06
Ray, N. et al. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 18, 671–677 (2006).
pubmed: 16569682 doi: 10.1093/intimm/dxl004
Li, A. et al. NUPR1 silencing induces autophagy-mediated apoptosis in multiple myeloma cells through the PI3K/AKT/mTOR pathway. DNA Cell Biol. 39, 368–378 (2020).
pubmed: 31971825 doi: 10.1089/dna.2019.5196
Hui, K. K., Chen, Y. K., Endo, R. & Tanaka, M. Translation from the ribosome to the clinic: implication in neurological disorders and new perspectives from recent advances. Biomolecules 9, 680 (2019).
Tattoli, I. et al. Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 11, 563–575 (2012).
pubmed: 22704617 doi: 10.1016/j.chom.2012.04.012
Biasizzo, M. & Kopitar-Jerala, N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol 11, 591803 (2020).
pubmed: 33163006 pmcid: 7583715 doi: 10.3389/fimmu.2020.591803
Takahara, T., Amemiya, Y., Sugiyama, R., Maki, M. & Shibata, H. Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes. J. Biomed. Sci. 27, 87 (2020).
pubmed: 32799865 pmcid: 7429791 doi: 10.1186/s12929-020-00679-2
Chow, S., Minden, M. D. & Hedley, D. W. Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients. Exp. Hematol. 34, 1183–1191 (2006).
pubmed: 16939811 doi: 10.1016/j.exphem.2006.05.002
Wu, X., Xie, W., Xie, W., Wei, W. & Guo, J. Beyond controlling cell size: functional analyses of S6K in tumorigenesis. Cell Death Dis. 13, 646 (2022).
pubmed: 35879299 pmcid: 9314331 doi: 10.1038/s41419-022-05081-4
Lynch, C. J. Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J. Nutr. 131, 861S–865S (2001).
pubmed: 11238775 doi: 10.1093/jn/131.3.861S
Austyn, J. M. & Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805–815 (1981).
pubmed: 7308288 doi: 10.1002/eji.1830111013
Moore, J. A. et al. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation. J Clin Invest 132, e153157 (2022).
Markham, M. & Troeberg, L. Using siRNA silencing to analyze ADAM17 in macrophages. Methods Mol. Biol. 2747, 119–129 (2024).
pubmed: 38038936 doi: 10.1007/978-1-0716-3589-6_10
Bourke, C. D., Berkley, J. A. & Prendergast, A. J. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 37, 386–398 (2016).
pubmed: 27237815 pmcid: 4889773 doi: 10.1016/j.it.2016.04.003
Shukla, S., Telraja, J., Yadav, M. & Prakash, H. Editorial: modulation of macrophage signaling pathways during bacterial infections. Front. Cell Infect. Microbiol. 11, 689759 (2021).
pubmed: 34211857 pmcid: 8240064 doi: 10.3389/fcimb.2021.689759
Corware, K. et al. Protein energy malnutrition increases arginase activity in monocytes and macrophages. Nutr. Metab. (Lond.) 11, 51 (2014).
pubmed: 25392710 doi: 10.1186/1743-7075-11-51
Redmond, H. P. et al. Impaired macrophage function in severe protein-energy malnutrition. Arch. Surg. 126, 192–196 (1991).
pubmed: 1847038 doi: 10.1001/archsurg.1991.01410260080011
Mass, E., Nimmerjahn, F., Kierdorf, K. & Schlitzer, A. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat. Rev. Immunol. 23, 563–579 (2023).
pubmed: 36922638 doi: 10.1038/s41577-023-00848-y
Payen, D. et al. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med. 34, 1371–1376 (2008).
pubmed: 18392609 doi: 10.1007/s00134-008-1048-1
van Zoelen, M. A. et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 180, 1098–1106 (2009).
pubmed: 19762566 doi: 10.1164/rccm.200810-1552OC
Audet-Walsh, E. et al. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer. Genes Dev. 31, 1228–1242 (2017).
pubmed: 28724614 pmcid: 5558925 doi: 10.1101/gad.299958.117
Chaveroux, C. et al. Molecular and genetic crosstalks between mTOR and ERRalpha are key determinants of rapamycin-induced nonalcoholic fatty liver. Cell Metab. 17, 586–598 (2013).
pubmed: 23562079 doi: 10.1016/j.cmet.2013.03.003
Ko, J. H., Yoon, S. O., Lee, H. J. & Oh, J. Y. Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFkappaB pathways in autophagy- and p62-dependent manners. Oncotarget 8, 40817–40831 (2017).
pubmed: 28489580 pmcid: 5522223 doi: 10.18632/oncotarget.17256
Ma, Y., Galluzzi, L., Zitvogel, L. & Kroemer, G. Autophagy and cellular immune responses. Immunity 39, 211–227 (2013).
pubmed: 23973220 doi: 10.1016/j.immuni.2013.07.017
Harris, J. et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J. Biol. Chem. 286, 9587–9597 (2011).
pubmed: 21228274 pmcid: 3058966 doi: 10.1074/jbc.M110.202911
Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264–268 (2008).
pubmed: 18849965 doi: 10.1038/nature07383
Wang, X. et al. Macrophage-specific hypoxia-inducible factor-1alpha contributes to impaired autophagic flux in nonalcoholic steatohepatitis. Hepatology 69, 545–563 (2019).
pubmed: 30102772 doi: 10.1002/hep.30215
Melnik, B. C. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J. Diabetes 3, 38–53 (2012).
pubmed: 22442749 pmcid: 3310004 doi: 10.4239/wjd.v3.i3.38
Huttunen, R., Laine, J., Lumio, J., Vuento, R. & Syrjanen, J. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect. Dis. 7, 13 (2007).
pubmed: 17349033 pmcid: 1831474 doi: 10.1186/1471-2334-7-13
Pugliese, G. et al. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int. J. Obes. (Lond.) 46, 449–465 (2022).
pubmed: 35058571 doi: 10.1038/s41366-021-01035-6

Auteurs

Edyta E Wojtowicz (EE)

Earlham Institute, Cellular Genomics Strategic Programme, Norwich Research Park, Norwich, UK, Norwich Research Park, Norwich, UK.

Katherine Hampton (K)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK.

Mar Moreno-Gonzalez (M)

Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Food, Microbiome and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Microbes and Food Safety Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Charlotte L Utting (CL)

Earlham Institute, Cellular Genomics Strategic Programme, Norwich Research Park, Norwich, UK, Norwich Research Park, Norwich, UK.

Yuxuan Lan (Y)

Earlham Institute, Cellular Genomics Strategic Programme, Norwich Research Park, Norwich, UK, Norwich Research Park, Norwich, UK.

Paula Ruiz (P)

Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Food, Microbiome and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Microbes and Food Safety Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Gemma Beasy (G)

Food, Microbiome and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Caitlin Bone (C)

Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Charlotte Hellmich (C)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK.
Department of Haematology, Norfolk and Norwich University Hospital, Norwich, UK.

Rebecca Maynard (R)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK.

Luke Acton (L)

Microbes and Food Safety Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Matthew Markham (M)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK.

Linda Troeberg (L)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK.

Andrea Telatin (A)

Science Operations, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.

Robert A Kingsley (RA)

Department of Haematology, Norfolk and Norwich University Hospital, Norwich, UK.
School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK.

Iain C Macaulay (IC)

Earlham Institute, Cellular Genomics Strategic Programme, Norwich Research Park, Norwich, UK, Norwich Research Park, Norwich, UK.

Stuart A Rushworth (SA)

Metabolic Health Research Centre, Faculty of Medicine, University of East Anglia, Norwich Research Park, Norwich, UK. s.rushworth@uea.ac.uk.

Naiara Beraza (N)

Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. naiara.beraza@quadram.ac.uk.
Food, Microbiome and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. naiara.beraza@quadram.ac.uk.
Microbes and Food Safety Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. naiara.beraza@quadram.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH